Differential Response of Cancer Cells to HDAC Inhibitors Trichostatin a and Depsipeptide

British Journal of Cancer - United Kingdom
doi 10.1038/bjc.2011.532
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

HDAC Inhibitors Enhance the Immunotherapy Response of Melanoma Cells

Oncotarget
Oncology
2017English

Effects of DNMT and HDAC Inhibitors (RG108 and Trichostatin A) on NGF-induced Neurite Outgrowth and Cellular Migration

International Journal of Pharmacology
Pharmacology
2016English

New and Emerging HDAC Inhibitors for Cancer Treatment

Journal of Clinical Investigation
Medicine
2014English

HDAC Inhibitors Show Benefits in Breast Cancer

Cancer Discovery
Oncology
2011English

In Vivo Screening Using Transgenic Zebrafish Embryos Reveals New Effects of HDAC Inhibitors Trichostatin a and Valproic Acid on Organogenesis

PLoS ONE
Multidisciplinary
2016English

Effects of Novel HDAC Inhibitors on Urothelial Carcinoma Cells

Clinical Epigenetics
GeneticsDevelopmental BiologyMolecular Biology
2018English

Differential Cellular and Molecular Effects of Butyrate and Trichostatin a on Vascular Smooth Muscle Cells

Pharmaceuticals
Molecular MedicinePharmaceutical Science
2012English

Lacking Cytokine Production in ES Cells and ES-cell-derived Vascular Cells Stimulated by TNF- Is Rescued by HDAC Inhibitor Trichostatin A

American Journal of Physiology - Cell Physiology
PhysiologyCell Biology
2007English

Understanding Failure and Improving Treatment Using HDAC Inhibitors for Prostate Cancer

Biomedicines
BiochemistryMedicineGeneticsMolecular Biology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy